US Broker Ratings

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Promising 172.86% Upside Potential in Biotech

Sionna Therapeutics, Inc. (SION), a burgeoning entity within the biotechnology sector, is capturing investor attention with an enticing potential upside of 172.86%. As a clinical-stage biopharmaceutical company, Sionna is dedicated..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 71% Potential Upside Sparks Investor Interest

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices sector, presents a unique investment opportunity with its innovative ultrasound imaging solutions. Headquartered in Burlington, Massachusetts, Butterfly Network..

Orthofix Medical Inc. (OFIX)

⚠️ No article content returned.

..

Surmodics, Inc. (SRDX) Investor Outlook: A Healthcare Innovator with 45.61% Potential Upside

Surmodics, Inc. (NASDAQ: SRDX), a pivotal player in the healthcare sector, is drawing investor attention with a robust potential upside of 45.61%. Specializing in medical devices and in vitro diagnostics,..

Standard BioTools Inc. (LAB) Investor Outlook: Exploring a 124% Upside Potential

Standard BioTools Inc. (NASDAQ: LAB) presents a unique opportunity for investors in the healthcare sector, particularly within the medical devices industry. Despite facing several challenges, the company’s stock is currently..

Autolus Therapeutics (AUTL) Stock Report: Analyzing the 469% Potential Upside in Biotech

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with an enticing potential upside of 469.52%. Known for its pioneering work in..

Verastem, Inc. (VSTM) Stock Analysis: A Biotech with Over 100% Potential Upside

Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with its significant potential upside in the biotechnology sector. With a market cap of approximately $426.96 million, Verastem is a..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 341% Potential Upside in the Biotech Sector

Investors with an eye on the biotechnology sector may find Precigen, Inc. (NASDAQ: PGEN) a compelling opportunity given its potential for significant upside. With a market capitalization of $410.3 million,..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 25% Potential Upside in the Health Information Services Sector

Definitive Healthcare Corp. (NASDAQ: DH) stands as a key player in the healthcare sector, providing a comprehensive software-as-a-service (SaaS) platform that delivers valuable commercial intelligence to a wide range of..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 345% Potential Upside in the Biotech Sector

Kura Oncology, Inc. (NASDAQ: KURA) has emerged as a compelling player in the biotechnology sector, primarily focusing on developing targeted cancer therapies. With a market capitalization of approximately $503.86 million,..

Embecta Corp. (EMBC): Investor Outlook with a Promising 69.78% Potential Upside

Embecta Corp. (EMBC), a company deeply rooted in the healthcare sector, specializes in medical instruments and supplies. Founded in 1924 and based in Parsippany, New Jersey, Embecta is a stalwart..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a Potential 313% Upside

For investors seeking opportunities in the biotechnology sector, AbCellera Biologics Inc. (NASDAQ: ABCL) presents an intriguing prospect. With a market capitalization of approximately $608.91 million, this Canadian-based company is making..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Report: Navigating Challenges with a 13.10% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a pioneering player in the biotechnology sector, has garnered attention for its innovative approach to cell programming. Despite facing some financial turbulence, Ginkgo’s growth..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Insights into Growth Potential and Market Position

Fulgent Genetics, Inc. (NASDAQ: FLGT), operating within the dynamic healthcare sector of diagnostics and research, presents an intriguing opportunity for investors looking to capitalize on the cutting-edge advancements in clinical..

CeriBell, Inc. (CBLL) Stock Analysis: Healthcare Innovator with 82% Upside Potential

CeriBell, Inc. (CBLL), a medical technology company specializing in cutting-edge neurology solutions, is positioned at the intersection of healthcare innovation and investment opportunity. Headquartered in Sunnyvale, California, and operating in..

Tectonic Therapeutic, Inc. (TECX): Unpacking a Promising 269% Upside Potential

In the dynamic landscape of biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) stands out with its innovative approach to drug discovery and development. This Watertown, Massachusetts-based company is making waves with..

Fortrea Holdings Inc. (FTRE) Valuation Insights: A 61.98% Potential Upside Amidst Challenging Metrics

Fortrea Holdings Inc. (NASDAQ: FTRE), a notable player in the biotechnology sector, is capturing investor attention with a significant potential upside despite facing some challenging financial metrics. Based in Durham,..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unveiling a 217% Potential Upside in the Biotech Arena

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is making waves in the biotechnology sector with an impressive 217% potential upside, as suggested by analysts. Headquartered in Cambridge, Massachusetts, Cullinan is a clinical-stage..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Growth and Investor Potential

LifeMD, Inc. (NASDAQ: LFMD) is making significant strides within the telehealth sector, a rapidly expanding segment of the healthcare industry. With a current market cap of $522.19 million, LifeMD is..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Assessing the 25.96% Potential Upside

Sage Therapeutics, Inc. (NASDAQ: SAGE), a prominent player in the biotechnology sphere, is currently making waves in the healthcare sector with its focus on developing innovative brain health medicines. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds